Zobrazeno 1 - 10
of 1 377
pro vyhledávání: '"E, van Leeuwen"'
Autor:
Henriëtte M van Duijne, Nina E Berentzen, Roel CH Vermeulen, Jelle J Vlaanderen, Hans Kromhout, Katarzyna Jóźwiak, Anouk Pijpe, Matti A Rookus, Flora E van Leeuwen, Michael Schaapveld
Publikováno v:
Scandinavian Journal of Work, Environment & Health, Vol 50, Iss 7, Pp 536-544 (2024)
OBJECTIVE: This study aimed to prospectively investigate associations of working night shifts with weight gain in the Nightingale Study, a large cohort of female nurses. METHODS: This study included 36 273 registered nurses, who completed questionnai
Externí odkaz:
https://doaj.org/article/6c7d9cd51acc4db5bff63cebc0299065
Autor:
M. C. Liefaard, A. van der Voort, M. van Seijen, B. Thijssen, J. Sanders, S. Vonk, L. Mittempergher, R. Bhaskaran, L. de Munck, A. E. van Leeuwen-Stok, R. Salgado, H. M. Horlings, E. H. Lips, G. S. Sonke
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract Tumor-infiltrating lymphocytes (TILs) have been associated with outcomes in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy and trastuzumab. However, it remains unclear if TILs could be a prognostic and/or predicti
Externí odkaz:
https://doaj.org/article/dfc1b1ee02aa46cab23090ed7177554b
Autor:
A. Klaassen-Dekker, C. H. C. Drossaert, M. C. Van Maaren, A. E. Van Leeuwen-Stok, V. P. Retel, J. C. Korevaar, S. Siesling, on behalf of the NABOR project group
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Follow-up of curatively treated primary breast cancer patients consists of surveillance and aftercare and is currently mostly the same for all patients. A more personalized approach, based on patients’ individual risk of recurre
Externí odkaz:
https://doaj.org/article/49058356ce79496fa87979bbb504f267
Autor:
Eline M J Lammers, Josée M Zijlstra, Valesca P Retèl, Berthe M P Aleman, Flora E van Leeuwen, Annelies Nijdam
Publikováno v:
JMIR Research Protocols, Vol 13, p e55601 (2024)
BackgroundHodgkin lymphoma (HL) occurs at young ages, with the highest incidence between 20 and 40 years. While cure rates have improved to 80%-90% over the past decades, survivors of HL are at substantial risk of late treatment–related complicatio
Externí odkaz:
https://doaj.org/article/96733ba3b3c14f89b8567a50ad39b2a8
Autor:
Karin Kast, Esther M. John, John L. Hopper, Nadine Andrieu, Catherine Noguès, Emmanuelle Mouret-Fourme, Christine Lasset, Jean-Pierre Fricker, Pascaline Berthet, Véronique Mari, Lucie Salle, Marjanka K. Schmidt, Margreet G. E. M. Ausems, Encarnacion B. Gomez Garcia, Irma van de Beek, Marijke R. Wevers, D. Gareth Evans, Marc Tischkowitz, Fiona Lalloo, Jackie Cook, Louise Izatt, Vishakha Tripathi, Katie Snape, Hannah Musgrave, Saba Sharif, Jennie Murray, EMBRACE Collaborators, Sarah V. Colonna, Irene L. Andrulis, Mary B. Daly, Melissa C. Southey, Miguel de la Hoya, Ana Osorio, Lenka Foretova, Dita Berkova, Anne-Marie Gerdes, Edith Olah, Anna Jakubowska, Christian F. Singer, Yen Tan, Annelie Augustinsson, Johanna Rantala, Jacques Simard, Rita K. Schmutzler, Roger L. Milne, Kelly-Anne Phillips, Mary Beth Terry, David Goldgar, Flora E. van Leeuwen, Thea M. Mooij, Antonis C. Antoniou, Douglas F. Easton, Matti A. Rookus, Christoph Engel
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-13 (2023)
Abstract Introduction Height, body mass index (BMI), and weight gain are associated with breast cancer risk in the general population. It is unclear whether these associations also exist for carriers of pathogenic variants in the BRCA1 or BRCA2 genes
Externí odkaz:
https://doaj.org/article/defb634c771140469f2099e850871259
Autor:
M. C. Liefaard, A. van der Voort, M. S. van Ramshorst, J. Sanders, S. Vonk, H. M. Horlings, S. Siesling, L. de Munck, A. E. van Leeuwen, M. Kleijn, L. Mittempergher, M. M. Kuilman, A. M. Glas, J. Wesseling, E. H. Lips, G. S. Sonke
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-15 (2023)
Abstract Background The introduction of pertuzumab has greatly improved pathological complete response (pCR) rates in HER2-positive breast cancer, yet effects on long-term survival have been limited and it is uncertain which patients derive most bene
Externí odkaz:
https://doaj.org/article/bfa7c6239ce5491780fe72525f695abc
Autor:
Emilie C H Breekveldt, Berbel L M Ykema, Alwin D R Huitema, Jourik A Gietema, Jos H Beijnen, Petur Snaebjornsson, Michael Schaapveld, Flora E van Leeuwen, Hilde Rosing, Monique E van Leerdam, CATCHER study working group
Publikováno v:
PLoS ONE, Vol 19, Iss 11, p e0312994 (2024)
Testicular cancer survivors (TCS) treated with platinum-based chemotherapy have increased cancer risk. Platinum retention in healthy tissue may contribute to carcinogenesis. We assessed total platinum concentrations in plasma, urine, and normal colon
Externí odkaz:
https://doaj.org/article/14543b93e99a4952b97ed838006ebac9
Publikováno v:
Epidemics, Vol 44, Iss , Pp 100709- (2023)
Relaxing social distancing measures and reduced level of influenza over the last two seasons may lead to a winter 2022 influenza wave in England. We used an established model for influenza transmission and vaccination to evaluate the rolled out influ
Externí odkaz:
https://doaj.org/article/9474e59f34d949b6ab24418533278766
Autor:
Jenna E. van Leeuwen, Wail Ba-Alawi, Emily Branchard, Jennifer Cruickshank, Wiebke Schormann, Joseph Longo, Jennifer Silvester, Peter L. Gross, David W. Andrews, David W. Cescon, Benjamin Haibe-Kains, Linda Z. Penn, Deena M. A. Gendoo
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Statins are promising for breast cancer therapy; dipyridamole can potentiate their effects, but is contraindicated in some cases. Here, the authors develop a pharmacogenomics pipeline to predict other compounds that potentiate statins, and validate t
Externí odkaz:
https://doaj.org/article/f57984f909454f0787ee786ab65589d9
Autor:
Frances K. Duane, Naomi B. Boekel, Judy N. Jacobse, Zhe Wang, Berthe M.P. Aleman, Sarah C. Darby, Michael Schaapveld, Flora E. van Leeuwen, Margreet H.A. Baaijens, Samantha Warren, Carolyn W. Taylor
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 36, Iss , Pp 132-139 (2022)
Purpose: To describe cardiac exposure from breast cancer radiotherapy regimens used during 1970–2009 for the development of dose–response relationships and to consider the associated radiation-risks using existing dose–response relationships. M
Externí odkaz:
https://doaj.org/article/4d7e64446ea44ee18ff685b203788b3a